Cancer continues to be a major burden on healthcare systems across the world, with global spending on therapies and supportive care drugs expected to reach $200 billion by 2022. The number of deaths worldwide has increased every year for decades, from 5.7 million in 1990 to 8.8 million in 2017. Kai Lipinski at Vibalogics explains how to bring the oncolytic virus to market.
Current Edition
Current Features
Subsection - Neurodegenerative Diseases
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue reading
How to Bring Your Oncolytic Virus Innovation to Market: the Secret to Successful Development
